-
EP4340948
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4340948
| EP4340948 - SYNTHETIC PROTEIN FOR INDUCING IMMUNE TOLERANCE [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 23.02.2024 Database last updated on 31.08.2024 | |
| Former | The international publication has been made Status updated on 26.11.2022 | Most recent event Tooltip | 19.07.2024 | Change: Validation states | published on 21.08.2024 [2024/34] | 19.07.2024 | Change - extension states | published on 21.08.2024 [2024/34] | Applicant(s) | For all designated states Wisconsin Alumni Research Foundation (WARF) 614 Walnut Street Madison, WI 53726 / US | [2024/13] | Inventor(s) | 01 /
GALIPEAU, Jacques Madison, WI 53705 / US | 02 /
PAUL, Pradyut Madison, WI 53705 / US | [2024/13] | Representative(s) | Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | [2024/13] | Application number, filing date | 22805328.6 | 17.05.2022 | [2024/13] | WO2022US29653 | Priority number, date | US202163189359P | 17.05.2021 Original published format: US 202163189359 P | [2024/13] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022245841 | Date: | 24.11.2022 | Language: | EN | [2022/47] | Type: | A1 Application with search report | No.: | EP4340948 | Date: | 27.03.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.11.2022 takes the place of the publication of the European patent application. | [2024/13] | Search report(s) | International search report - published on: | US | 24.11.2022 | Classification | IPC: | A61P37/04, A61K39/39, A61P35/00, A61P37/02 | [2024/13] | CPC: |
A61P37/04 (EP);
A61K35/39 (US);
A61P3/10 (US);
A61P35/00 (EP);
A61P37/02 (EP);
A61P37/06 (US);
C07K14/70532 (EP,US);
C12N15/86 (US);
C12N5/0676 (EP,US);
C12N9/0069 (EP,US);
C12Y113/11052 (EP,US);
A61K35/00 (EP);
A61K38/00 (EP);
C07K2319/00 (EP);
C07K2319/02 (US);
C07K2319/03 (EP,US);
C07K2319/74 (EP);
C12N2501/48 (EP);
C12N2501/71 (EP);
C12N2501/998 (EP);
C12N2510/00 (EP,US);
C12N2740/15043 (US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/13] | Title | German: | SYNTHETISCHES PROTEIN ZUR INDUZIERUNG VON IMMUNTOLERANZ | [2024/13] | English: | SYNTHETIC PROTEIN FOR INDUCING IMMUNE TOLERANCE | [2024/13] | French: | PROTÉINE SYNTHÉTIQUE POUR INDUIRE UNE TOLÉRANCE IMMUNITAIRE | [2024/13] | Entry into regional phase | 16.11.2023 | National basic fee paid | 16.11.2023 | Search fee paid | 16.11.2023 | Designation fee(s) paid | 16.11.2023 | Examination fee paid | Examination procedure | 16.11.2023 | Examination requested [2024/13] | 27.06.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 13.03.2024 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2013056716 (HERLEV HOSPITAL [DK]); | [X]US2017239337 (ANDERSEN MADS HALD [DK]); | [A]US2019343940 (ANDERSEN MADS HALD [DK]); |